Carlos Melo has a degree in chemistry and a PhD in biological chemistry. In 30 years of career developed the firsts biossimilars commercialized in the world -launched in Argentina at the beggining of the 90´, the firsts cloned and transgenic cows in Latam, and the first gene therapy treatment developed in the region that arrived to clinical trials. Is currently Director of Science and technology of the City of Buenos Aires.